Evoke Pharma Inc: Nasdaq/NYSE listing notice — Evoke Pharma receives Nasdaq delisting notice for failure to meet minimum equity requirement

Evoke Pharma Inc

Received delisting notice from Nasdaq on Nov 21, 2023 for non-compliance with minimum stockholders' equity of $2.5M.
Previously granted extension until Nov 20, 2023 to regain compliance; failed to do so.
Company plans to timely request a hearing before Nasdaq Hearings Panel to stay delisting.
Actively exploring options to regain compliance, including raising additional capital.
No assurance that hearing will grant continued listing or that compliance can be achieved.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Evoke Pharma Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

November 21, 2023, the Company received notice from Nasdaq that, due to the Company’s non-compliance with the Minimum Stockholders’ Equity Requirement, the Company was subject to delisting unless it timely requests a hearing before the Nasdaq Hearings Panel (the “Hearings Panel”). The Company plans to timely request a hearing before the Hearings Panel, which request will stay any further action by Nasdaq pending the conclusion of the hearing process. The Company is actively exploring options to regain compliance with Nasdaq listing requirements, including by raising additional capital; however

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-23-065881

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.